Condition
Postoperative Hypoparathyroidism
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07491601Not ApplicableRecruitingPrimary
PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"
NCT05579782Not ApplicableCompletedPrimary
Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy
NCT04281875Not ApplicableCompletedPrimary
Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy.
NCT05186883Phase 1UnknownPrimary
Treatment of Postoperative Hypoparathyroidism Using Cultured Allogenic Parathyroid Cells
Showing all 4 trials